{
    "other_tests": [
        {
            "procedure_name": "Genetic Testing",
            "date": "Not specified",
            "findings": "Positive for 2 pathogenic variants (p.P1007A and p.1077Q) of NPC1 gene.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "NPC suspicion index score assessment",
            "date": "Not specified",
            "findings": "Score 61.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Neurologic Examination",
            "date": "Not specified",
            "findings": "Normal cognition, dysarthric speech, reduced vertical gaze, intact horizontal eye movements, bilateral sensorineural hearing loss, generalized myoclonic jerks, marked gait ataxia, normal abdominal examination.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Response to Valproate",
            "date": "Not specified",
            "findings": "Myoclonic jerks improved.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Miglustat Therapy Initiation",
            "date": "Not specified",
            "findings": "Started on miglustat 100 mg oral twice daily, titrated to 200 mg oral 3 times a day.",
            "changes_over_time": "Clinical improvement reported by 6 months to 1 year of drug use."
        }
    ]
}